Cargando…

Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction

OBJECTIVE: Although the importance of evidence-based optimal medical therapy (OMT) after acute myocardial infarction (AMI) has been recognized, the prescription rate of OMT is not sufficiently high in real-word clinical settings. The purpose of this study was to identify the clinical characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Haraguchi, Yumiko, Sakakura, Kenichi, Yamamoto, Kei, Taniguchi, Yousuke, Tsukui, Takunori, Seguchi, Masaru, Wada, Hiroshi, Momomura, Shin-ichi, Fujita, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364243/
https://www.ncbi.nlm.nih.gov/pubmed/32188806
http://dx.doi.org/10.2169/internalmedicine.4016-19
_version_ 1783559803967111168
author Haraguchi, Yumiko
Sakakura, Kenichi
Yamamoto, Kei
Taniguchi, Yousuke
Tsukui, Takunori
Seguchi, Masaru
Wada, Hiroshi
Momomura, Shin-ichi
Fujita, Hideo
author_facet Haraguchi, Yumiko
Sakakura, Kenichi
Yamamoto, Kei
Taniguchi, Yousuke
Tsukui, Takunori
Seguchi, Masaru
Wada, Hiroshi
Momomura, Shin-ichi
Fujita, Hideo
author_sort Haraguchi, Yumiko
collection PubMed
description OBJECTIVE: Although the importance of evidence-based optimal medical therapy (OMT) after acute myocardial infarction (AMI) has been recognized, the prescription rate of OMT is not sufficiently high in real-word clinical settings. The purpose of this study was to identify the clinical characteristics of AMI patients who did not receive OMT. METHODS: The present study was a retrospective study. OMT was defined as the combination of antiplatelet therapy, angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs), beta-blockers, and statins at the time of hospital discharge. Non-OMT was defined as the lack of either antiplatelet therapy, ACE inhibitors/ARBs, beta-blockers, or statins. RESULTS: A total of 457 AMI patients were included as the final study population, and 98 patients (22.4%) lacked at least 1 OMT medication. The prescription rates of antiplatelet therapy, ACE inhibitors/ARBs, beta-blockers, and statins were 98.7%, 87.5%, 90.4%, and 96.7%, respectively. In the multivariate logistic regression analysis, age [per 1-year increase: odds ratio (OR) 1.033, 95% confidence interval (CI) 1.007-1.059, p=0.014], hemodialysis (vs. no hemodialysis: OR 2.707, 95% CI 1.082-6.774, p=0.033), estimated glomerular filtration rate <30 mL/min/1.73 m(2) without hemodialysis (OR 4.585, 95% CI 1.975-10.644, p<0.001), AMI caused by vasospastic angina (VSA) (vs. no VSA: OR 13.198, 95% CI 1.809-96.260, p=0.011), and asthma (vs. no asthma: OR 7.241, 95% CI 1.716-30.559, p=0.007) were significantly associated with non-OMT, whereas heart rate on admission (per 1-bpm increase: 0.987, 95% CI 0.975-0.999, p=0.033), any PCI (vs. no PCI: OR 0.156, 95% CI 0.066-0.373, p<0.001), and ST-elevation myocardial infarction (STEMI) (vs. NSTEMI: OR 0.384, 95% CI 0.218-0.675, p=0.001) were inversely associated with non-OMT. CONCLUSION: An advanced age, VSA, bradycardia, asthma, impaired renal function, non-PCI revascularization, and non-ST-elevation myocardial infarction were significantly associated with non-OMT.
format Online
Article
Text
id pubmed-7364243
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-73642432020-07-30 Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction Haraguchi, Yumiko Sakakura, Kenichi Yamamoto, Kei Taniguchi, Yousuke Tsukui, Takunori Seguchi, Masaru Wada, Hiroshi Momomura, Shin-ichi Fujita, Hideo Intern Med Original Article OBJECTIVE: Although the importance of evidence-based optimal medical therapy (OMT) after acute myocardial infarction (AMI) has been recognized, the prescription rate of OMT is not sufficiently high in real-word clinical settings. The purpose of this study was to identify the clinical characteristics of AMI patients who did not receive OMT. METHODS: The present study was a retrospective study. OMT was defined as the combination of antiplatelet therapy, angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs), beta-blockers, and statins at the time of hospital discharge. Non-OMT was defined as the lack of either antiplatelet therapy, ACE inhibitors/ARBs, beta-blockers, or statins. RESULTS: A total of 457 AMI patients were included as the final study population, and 98 patients (22.4%) lacked at least 1 OMT medication. The prescription rates of antiplatelet therapy, ACE inhibitors/ARBs, beta-blockers, and statins were 98.7%, 87.5%, 90.4%, and 96.7%, respectively. In the multivariate logistic regression analysis, age [per 1-year increase: odds ratio (OR) 1.033, 95% confidence interval (CI) 1.007-1.059, p=0.014], hemodialysis (vs. no hemodialysis: OR 2.707, 95% CI 1.082-6.774, p=0.033), estimated glomerular filtration rate <30 mL/min/1.73 m(2) without hemodialysis (OR 4.585, 95% CI 1.975-10.644, p<0.001), AMI caused by vasospastic angina (VSA) (vs. no VSA: OR 13.198, 95% CI 1.809-96.260, p=0.011), and asthma (vs. no asthma: OR 7.241, 95% CI 1.716-30.559, p=0.007) were significantly associated with non-OMT, whereas heart rate on admission (per 1-bpm increase: 0.987, 95% CI 0.975-0.999, p=0.033), any PCI (vs. no PCI: OR 0.156, 95% CI 0.066-0.373, p<0.001), and ST-elevation myocardial infarction (STEMI) (vs. NSTEMI: OR 0.384, 95% CI 0.218-0.675, p=0.001) were inversely associated with non-OMT. CONCLUSION: An advanced age, VSA, bradycardia, asthma, impaired renal function, non-PCI revascularization, and non-ST-elevation myocardial infarction were significantly associated with non-OMT. The Japanese Society of Internal Medicine 2020-03-19 2020-06-15 /pmc/articles/PMC7364243/ /pubmed/32188806 http://dx.doi.org/10.2169/internalmedicine.4016-19 Text en Copyright © 2020 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Haraguchi, Yumiko
Sakakura, Kenichi
Yamamoto, Kei
Taniguchi, Yousuke
Tsukui, Takunori
Seguchi, Masaru
Wada, Hiroshi
Momomura, Shin-ichi
Fujita, Hideo
Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction
title Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction
title_full Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction
title_fullStr Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction
title_full_unstemmed Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction
title_short Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction
title_sort determinants of insufficient optimal medical therapy after acute myocardial infarction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364243/
https://www.ncbi.nlm.nih.gov/pubmed/32188806
http://dx.doi.org/10.2169/internalmedicine.4016-19
work_keys_str_mv AT haraguchiyumiko determinantsofinsufficientoptimalmedicaltherapyafteracutemyocardialinfarction
AT sakakurakenichi determinantsofinsufficientoptimalmedicaltherapyafteracutemyocardialinfarction
AT yamamotokei determinantsofinsufficientoptimalmedicaltherapyafteracutemyocardialinfarction
AT taniguchiyousuke determinantsofinsufficientoptimalmedicaltherapyafteracutemyocardialinfarction
AT tsukuitakunori determinantsofinsufficientoptimalmedicaltherapyafteracutemyocardialinfarction
AT seguchimasaru determinantsofinsufficientoptimalmedicaltherapyafteracutemyocardialinfarction
AT wadahiroshi determinantsofinsufficientoptimalmedicaltherapyafteracutemyocardialinfarction
AT momomurashinichi determinantsofinsufficientoptimalmedicaltherapyafteracutemyocardialinfarction
AT fujitahideo determinantsofinsufficientoptimalmedicaltherapyafteracutemyocardialinfarction